Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

XIAP-mediated neuroprotection in retinal ischemia

Abstract

Retinal ischemia results in the loss of vision in a number of ocular diseases including acute glaucoma, diabetic retinopathy, hypertensive retinopathy and retinal vascular occlusion. Recent studies have shown that most of the neuronal death that leads to loss of vision results from apoptosis. XIAP-mediated gene therapy has been shown to protect a number of neuronal types from apoptosis but has never been assessed in retinal neurons following ischemic-induced cell death. We injected an adeno-associated viral vector expressing XIAP or GFP into rat eyes and 6 weeks later, rendered them ischemic by raising intraocular pressure. Functional analysis revealed that XIAP-treated eyes retained larger b-wave amplitudes than GFP-treated eyes up to 4 weeks post-ischemia. The number of cells in the inner nuclear layer (INL) and the thickness of the inner retina were significantly preserved in XIAP-treated eyes compared to GFP-treated eyes. Similarly, there was no significant reduction in optic nerve axon numbers in XIAP-treated eyes. There were also significantly fewer TUNEL (TdT-dUTP terminal nick end labeling) positive cells in the INL of XIAP-treated retinas at 24 h post-ischemia. Thus, XIAP-mediated gene therapy imparts both functional and structural protection to the retina after a transient ischemic episode.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Kohner EM . Diabetic retinopathy. Br Med Bull 1989; 45: 148–173.

    Article  CAS  Google Scholar 

  2. Mattson MP, Duan W, Pedersen WA, Culmsee C . Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001; 6: 69–81.

    Article  CAS  Google Scholar 

  3. Rosenbaum DM, Rosenbaum PS, Gupta A, Michaelson MD, Hall DH, Kessler JA . Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res 1997; 37: 3445–3451.

    Article  CAS  Google Scholar 

  4. Rosenbaum PS, Gupta H, Savitz SI, Rosenbaum DM . Apoptosis in the retina. Clin Neurosci 1997; 4: 224–232.

    CAS  PubMed  Google Scholar 

  5. Sucher NJ, Lipton SA, Dreyer EB . Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997; 37: 3483–3493.

    Article  CAS  Google Scholar 

  6. Luo X, Lambrou GN, Sahel JA, Hicks D . Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro. Invest Ophthalmol Vis Sci 2001; 42: 2695–2705.

    CAS  PubMed  Google Scholar 

  7. Adachi K, Kashii S, Masai H, Ueda M, Morizane C, Kaneda K et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol 1998; 236: 766–774.

    Article  CAS  Google Scholar 

  8. Rumelt S, Dorenboim Y, Rehany U . Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999; 128: 733–738.

    Article  CAS  Google Scholar 

  9. Seigel GM, Chiu L, Paxhia A . Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. Mol Vis 2000; 6: 157–163.

    CAS  PubMed  Google Scholar 

  10. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U . Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002; 22: RC216.

    Article  Google Scholar 

  11. Lafuente MP, Villegas-Perez MP, Selles-Navarro I, Mayor-Torroglosa S, Miralles de Imperial J, Vidal-Sanz M . Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience 2002; 109: 157–168.

    Article  CAS  Google Scholar 

  12. Schulz JB, Weller M, Moskowitz MA . Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45: 421–429.

    Article  CAS  Google Scholar 

  13. Katai N, Yoshimura N . Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci 1999; 40: 2697–2705.

    CAS  PubMed  Google Scholar 

  14. Singh M, Savitz SI, Hoque R, Gupta G, Roth S, Rosenbaum PS et al. Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J Neurochem 2001; 77: 466–475.

    Article  CAS  Google Scholar 

  15. Liston P, Fong WG, Korneluk RG . The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003; 22: 8568–8580.

    Article  CAS  Google Scholar 

  16. Wang J, Lenardo MJ . Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 2000; 113 (Part 5): 753–757.

    CAS  PubMed  Google Scholar 

  17. MacFarlane M, Merrison W, Bratton SB, Cohen GM . Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 2002; 277: 36611–36616.

    Article  CAS  Google Scholar 

  18. Deveraux QL, Takahashi R, Salvesen GS, Reed JC . X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300–304.

    Article  CAS  Google Scholar 

  19. Holcik M, Gibson H, Korneluk RG . XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001; 6: 253–261.

    Article  CAS  Google Scholar 

  20. McKinnon SJ, Lehman DM, Tahzib NG, Ransom NL, Reitsamer HA, Liston P et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 2002; 5: 780–787.

    Article  CAS  Google Scholar 

  21. Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2000; 20: 9126–9134.

    Article  CAS  Google Scholar 

  22. Petrin D, Baker A, Coupland SG, Liston P, Narang M, Damji K et al. Structural and functional protection of photoreceptors from MNU-induced retinal degeneration by the X-linked inhibitor of apoptosis. Invest Ophthalmol Vis Sci 2003; 44: 2757–2763.

    Article  Google Scholar 

  23. Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y et al. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci 1999; 19: 5026–5033.

    Article  CAS  Google Scholar 

  24. Petrin D, Baker A, Brousseau J, Coupland S, Liston P, Hauswirth WW et al. XIAP protects photoreceptors from n-methyl-n-nitrosourea-induced retinal degeneration. Adv Exp Med Biol 2003; 533: 385–393.

    Article  CAS  Google Scholar 

  25. Unoki K, LaVail MM . Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994; 35: 907–915.

    CAS  PubMed  Google Scholar 

  26. Delaey C, Van De Voorde J . Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res 2000; 32: 249–256.

    Article  CAS  Google Scholar 

  27. Gross RL, Hensley SH, Gao F, Wu SM . Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Surv Ophthalmol 1999; 43 (Suppl 1): S162–S170.

    Article  Google Scholar 

  28. Chun MH, Kim IB, Ju WK, Kim KY, Lee MY, Joo CK et al. Horizontal cells of the rat retina are resistant to degenerative processes induced by ischemia-reperfusion. Neurosci Lett 1999; 260: 125–128.

    Article  CAS  Google Scholar 

  29. Winkler BS, Arnold MJ, Brassell MA, Puro DG . Energy metabolism in human retinal Muller cells. Invest Ophthalmol Vis Sci 2000; 41: 3183–3190.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Kolb H . Anatomical pathways for color vision in the human retina. Vis Neurosci 1991; 7: 61–74.

    Article  CAS  Google Scholar 

  31. Jander S, Schroeter M, D'Urso D, Gillen C, Witte OW, Stoll G . Focal ischaemia of the rat brain elicits an unusual inflammatory response: early appearance of CD8+ macrophages/microglia. Eur J Neurosci 1998; 10: 680–688.

    Article  CAS  Google Scholar 

  32. Knox DL, Kerrison JB, Green WR . Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000; 98: 203–220.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Zhang C, Lam TT, Tso MO . Heterogeneous populations of microglia/macrophages in the retina and their activation after retinal ischemia and reperfusion injury. Exp Eye Res 2005: 1–10.

  34. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N . A ‘humanized’ green fluoresenct protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646–4654.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Timmers AM, Zhang H, Squitieri A, Gonzalez-Pola C . Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina. Mol Vis 2001; 7: 131–137.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr Peter Liston for reagents and Sandra L Hurley, Sarah Ikeda, Brendan Joyce and Vince Chiodo for technical assistance. We also thank Louise Pelletier for processing optic nerve cross-sections for our studies, Isabelle Gaboury for assistance with statistical analysis and Drs Rashmi Kothari and Valerie Wallace for analysis of glial tissue infiltration of optic nerve cross-sections. These studies were supported by a Grant from the Canadian Institute for Health Research (CIHR). WWH and the University of Florida could be entitled to patent royalties for inventions related to this work and both own equity in a company that may commercialize some of the technology described herein.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Tsilfidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renwick, J., Narang, M., Coupland, S. et al. XIAP-mediated neuroprotection in retinal ischemia. Gene Ther 13, 339–347 (2006). https://doi.org/10.1038/sj.gt.3302683

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302683

Keywords

This article is cited by

Search

Quick links